Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AR | P10275 | 5/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | XDH | P47989 | 1/20 | 0.33 |
| ▸ | ALOX5AP | P20292 | 1/20 | 0.32 |
| ▸ | FEN1 | P39748 | 1/20 | 0.32 |
| ▸ | HCRTR1 | O43613 | 2/20 | 0.32 |
| ▸ | HCRTR2 | O43614 | 2/20 | 0.32 |
| ▸ | BCAT1 | P54687 | 1/20 | 0.31 |
| ▸ | HTR6 | P50406 | 2/20 | 0.31 |
| ▸ | HRH1 | P35367 | 1/20 | 0.31 |
| ▸ | RAF1 | P04049 | 1/20 | 0.31 |
| ▸ | BRAF | P15056 | 1/20 | 0.31 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21399450 | 0.96 | AR (0.36) | ARTSHRSMN1; SMN2XDHALOX5AP | |
| SCHEMBL22985667 | 0.95 | ALOX5AP (0.36) | ARTSHRSMN1; SMN2XDHALOX5AP | |
| SCHEMBL22985225 | 0.92 | ALOX5AP (0.35) | ARTSHRSMN1; SMN2XDHALOX5AP | |
| SCHEMBL20849225 | 0.92 | AR (0.35) | ARXDH | |
| SCHEMBL21399572 | 0.92 | TSHR (0.36) | ARTSHRSMN1; SMN2XDHALOX5AP | |
| SCHEMBL20849517 | 0.91 | AR (0.37) | ARTSHRSMN1; SMN2 | |
| SCHEMBL21399501 | 0.90 | TSHR (0.39) | ARTSHRSMN1; SMN2HTR6HRH1 | |
| SCHEMBL20848954 | 0.90 | AR (0.40) | AR | |
| SCHEMBL22985521 | 0.90 | ALOX5AP (0.39) | ARTSHRSMN1; SMN2XDHALOX5AP | |
| SCHEMBL22984987 | 0.89 | AR (0.37) | ARTSHRSMN1; SMN2XDHALOX5AP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190292151-A1 | ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO., LTD. (KR) | 2019-09-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190292151-A1 | ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES | OR10J3, NR2E3, FOXO3 | AR 1991/4885TSHR 260/4885SMN1; SMN2 3631/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.